Identification |
Name: | 4-Piperidinol,1-methyl- |
Synonyms: | 1-Methyl-4-hydroxypiperidine;1-Methyl-4-piperidinol;4-Hydroxy-1-methylpiperidine;4-Hydroxy-N-methylpiperidine;N-Methyl-4-hydroxypiperidine;NSC 60705; |
CAS: | 106-52-5 |
EINECS: | 203-406-8 |
Molecular Formula: | C6H13NO |
Molecular Weight: | 115.17 |
InChI: | InChI=1/C6H13NO/c1-7-4-2-6(8)3-5-7/h6,8H,2-5H2,1H3 |
Molecular Structure: |
|
Properties |
Density: | 1.005 g/cm3 |
Stability: | Stable at room temperature in closed containers under normal storage and handling conditions. |
Refractive index: | 1.476-1.479 |
Water Solubility: | MISCIBLE |
Solubility: | MISCIBLE |
Appearance: | Yellow liquid |
Specification: | clear colorless to yellowish liquid after melting usageEng:Reactant for:• ;Optimization of Novobiocin scaffold to product antitumor agents1• ;Substitution about the rigidifying ring for histamine H4 receptor antagonist synthesis2Reactant for synthesis of:• ;CaMKII inhibitors3• ;VEGFR and FGFR kinase inhibitors4• ;Phosphoinositide-3-kinase inhibitors5• ;Protein lysine methyltransferase G9a inhibitors6 Safety Statements:26-37/39-45-36/37/39-27 26:In case of contact with eyes, rinse immediately with plenty
of water and seek medical advice 37/39:Wear suitable protective clothing, gloves and eye/face
protection 45:In case of accident or if you feel unwell, seek medical
advice immediately (show label where possible) 36/37/39:Wear suitable protective clothing, gloves and eye/face
protection 27:Take off immediately all contaminated clothing |
HS Code: | 29333999 |
Storage Temperature: | Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a cool, dry, well-ventilated area away from incompatible substances. Do not expose to air. Store protected from moisture. Store under an inert atmosphere. |
Sensitive: | Hygroscopic |
Usage: | Reactant for:• ;Optimization of Novobiocin scaffold to product antitumor agents1• ;Substitution about the rigidifying ring for histamine H4 receptor antagonist synthesis2Reactant for synthesis of:• ;CaMKII inhibitors3• ;VEGFR and FGFR kinase inhibitors4• ;Phosphoinositide-3-kinase inhibitors5• ;Protein lysine methyltransferase G9a inhibitors6 |
Safety Data |
Hazard Symbols |
Xi:Irritant
|
|
|